Patents by Inventor Peter Herrmann
Peter Herrmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250135107Abstract: Embodiments provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.Type: ApplicationFiled: January 3, 2025Publication date: May 1, 2025Applicant: Rani Therapeutics, LLCInventors: Mir IMRAN, Peter HERRMANN, Baber SYED, Timothy H. WILLIAMS, Chang Jin ONG, Greg METHOD
-
Patent number: 12263325Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.Type: GrantFiled: October 5, 2023Date of Patent: April 1, 2025Assignee: Rani Therapeutics, LLCInventors: Mir Imran, Peter Herrmann, Baber Syed, Timothy H. Williams, Chang Jin Ong, Greg Method
-
Publication number: 20240082488Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.Type: ApplicationFiled: October 5, 2023Publication date: March 14, 2024Applicant: Rani Therapeutics, LLCInventors: Mir IMRAN, Peter HERRMANN, Baber SYED, Timothy H. WILLIAMS, Chang Jin ONG, Greg METHOD
-
Patent number: 11806504Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.Type: GrantFiled: March 24, 2020Date of Patent: November 7, 2023Assignee: RANI THERAPEUTICS, LLCInventors: Mir A. Imran, Peter Herrmann, Baber Syed, Timothy H. Williams, Chang Jin Ong, Greg Method
-
Patent number: 11579010Abstract: A load cell includes a bearing element configured for a hoist that includes a hook, a suspension with an orifice that receives a shaft of the hook, a nut, and housing. The bearing element, preferably a ring, contacts the suspension, and has an orifice that receives the shaft therethrough with the nut secured to the shaft proximate to the bearing element. Strain gauges are mounted on the ring side wall being equally spaced. A second suspension orifice concentric with the first orifice receives the ring with strain gauges therein. For improved accuracy, a thrust roller bearing and two thrust washers are positioned on sides of the ring, all of which are preferably positioned in a cup member that is received in the second orifice. A clearance fit is provided with respect to each of protruding upper and lower overhanging cylindrical ring lips and the cup to protect the gauges.Type: GrantFiled: March 18, 2020Date of Patent: February 14, 2023Assignee: Motion Laboratories, Inc.Inventors: Peter Herrmann, Philip Nubile
-
Patent number: 11182601Abstract: A system for recognizing an operating intention at an operating unit that can be actuated manually includes an image capture unit for monitoring a capture region surrounding the operating unit for an entering hand in order to capture it in terms of a positioning of a palm of a hand or of one or a plurality of fingers in relation to the operating unit and to generate corresponding image information. An evaluation unit is provided for comparing the generated image information with at least one image pattern that is characteristic for an operating intention from a pattern memory. In the event of a correspondence that lies within a permitted variation range, a controllable function is enabled on the part of the operating unit.Type: GrantFiled: March 12, 2020Date of Patent: November 23, 2021Assignee: DEERE & COMPANYInventors: Christoph Wagner, Peter Herrmann
-
Publication number: 20200311399Abstract: A system for recognizing an operating intention at an operating unit that can be actuated manually includes an image capture unit for monitoring a capture region surrounding the operating unit for an entering hand in order to capture it in terms of a positioning of a palm of a hand or of one or a plurality of fingers in relation to the operating unit and to generate corresponding image information. An evaluation unit is provided for comparing the generated image information with at least one image pattern that is characteristic for an operating intention from a pattern memory. In the event of a correspondence that lies within a permitted variation range, a controllable function is enabled on the part of the operating unit.Type: ApplicationFiled: March 12, 2020Publication date: October 1, 2020Inventors: CHRISTOPH WAGNER, PETER HERRMANN
-
Publication number: 20200289747Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.Type: ApplicationFiled: March 24, 2020Publication date: September 17, 2020Inventors: Mir A. Imran, Peter Herrmann, Baber Syed, Timothy H. Williams, Chang Jin Ong, Greg Method
-
Patent number: 10632251Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.Type: GrantFiled: August 10, 2017Date of Patent: April 28, 2020Assignee: Rani Therapeutics, LLCInventors: Mir A. Imran, Peter Herrmann, Baber Syed, Timothy H. Williams, Chang Jin Ong, Greg Method
-
Publication number: 20180008771Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.Type: ApplicationFiled: August 10, 2017Publication date: January 11, 2018Applicant: Rani Therapeutics, LLCInventors: Mir A. Imran, Peter Herrmann, Baber Syed, Timothy H. Williams, Chang Jin Ong, Greg Method
-
Patent number: 9757514Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.Type: GrantFiled: April 3, 2014Date of Patent: September 12, 2017Assignee: Rani Therapeutics, LLCInventors: Mir A. Imran, Peter Herrmann, Baber Syed, Timothy H. Williams, Chang Jin Ong, Greg Method
-
Publication number: 20140221927Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.Type: ApplicationFiled: April 3, 2014Publication date: August 7, 2014Applicant: Rani Therapeutics, LLCInventors: Mir Imran, Peter Herrmann, Baber Syed, Timothy H. Williams, Chang Jin Ong, Greg Method
-
Patent number: 8734429Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.Type: GrantFiled: March 15, 2013Date of Patent: May 27, 2014Assignee: Rani Therapeutics, LLCInventors: Mir Imran, Peter Herrmann, Baber Syed, Timothy H. Williams, Chang Jin Ong, Greg Method
-
Publication number: 20130274659Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. Embodiments also provide various drug preparations that are configured to be contained within the capsule, advanced from the capsule into the intestinal wall and degrade within the wall to release the drug to produce a therapeutic effect. The preparation can be coupled to a delivery mechanism having one or more balloons or other expandable devices which are expandable responsive to a condition in the small intestine or other GI lumen to advance the preparation out of the capsule into the intestinal wall. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.Type: ApplicationFiled: March 15, 2013Publication date: October 17, 2013Applicant: InCube Labs, LLCInventors: Mir Imran, Peter Herrmann, Baber Syed, Timothy H. Williams, Chang Jin Ong, Greg Method
-
Patent number: 7442873Abstract: An improved enclosure for electrical components is provided. The enclosure protects components from the environment. The enclosure may rest on a surface and to move it from one location to another the enclosure may be rotated 90° and can travel on top and bottom side wall portions. There is a recessed portion between the top and bottom side wall portion where electrical connections may be present and do not interfere with movement of the enclosure.Type: GrantFiled: February 3, 2006Date of Patent: October 28, 2008Inventors: Sean McCormick, Peter Herrmann, William Froehlich
-
Publication number: 20070210087Abstract: An improved enclosure for electrical components is provided. The enclosure protects components from the environment. The enclosure may rest on a surface and to move it from one location to another the enclosure may be rotated 90° and can travel on top and bottom side wall portions. There is a recessed portion between the top and bottom side wall portion where electrical connections may be present and do not interfere with movement of the enclosure.Type: ApplicationFiled: February 3, 2006Publication date: September 13, 2007Inventors: Sean McCormick, Peter Herrmann, William Froehlich
-
Patent number: 6909966Abstract: A navigational device in which a position is storable by actuating a control element and this position may be input as a driving destination by re-actuating the control element. This simplifies the input of an often frequented driving destination such as a place of residence.Type: GrantFiled: July 4, 2002Date of Patent: June 21, 2005Assignee: Robert Bosch GmbHInventors: Walter Schaefer, Peter Herrmann
-
Publication number: 20040054466Abstract: A navigational device is described where a position is storable by actuating a control element and this position may be input as a driving destination by re-actuating the control element. This simplifies the input of an often frequented driving destination, e.g., the place of residence.Type: ApplicationFiled: September 25, 2003Publication date: March 18, 2004Inventors: Walter Schaefer, Peter Herrmann
-
Patent number: 6316236Abstract: A method is provided for preparing a highly purified lysozyme dimer product which comprises dimerizing the lysozyme monomer with a suberimidate coupling reagent in a buffer solution adjusted to pH 10, stopping the dimerization at a given point by lowering the pH to 7 via addition of HCl or other suitable acid solution, and purifying the dimeric lysozyme by a series of elution steps carried out using ion exchange resin column chromatography. Monomeric lysozyme remaining undimerized by the initial dimerization step is recycled into the process in order to increase yield. The present system is advantageous in that large amounts of purified lysozyme dimer can be prepared efficiently and relatively inexpensively, and the lysozyme dimer so produced is useful in treating viral and/or bacterial diseases without causing the cytotoxic effects associated with the lysozyme monomer.Type: GrantFiled: August 7, 1998Date of Patent: November 13, 2001Assignee: Nika Health Products LimitedInventors: Peter Herrmann, Peter Klein
-
Patent number: 6040167Abstract: The phospholipid bilayer contains at least one pharmaceutically active drug and comprises cell-specific markers on the membrane which have at least 90% biological activity when measured according to Luescher & Glueck, Antiviral Research 14, 39-50. In the membrane, the cholesterol content is preferably less than 2% by weight, the detergent content preferably less than 1 ppb. The vesicle diameter preferably is about 80 nm. the phospholipid in the membrane may comprise 70 to 95% by weight of phosphatidylcholine and preferably 10 to 20% by weight of phosphatidylethanolamine; preferably 6-8% by weight of a crosslinker, preferably of a sulfosuccinimidyl derivate, and at least one cell-specific fusion peptide are linked to the membrane. The vesicles are used for the preparation of pharmaceuticals against AIDS and carcinomas.Type: GrantFiled: November 2, 1992Date of Patent: March 21, 2000Assignee: Nika Health Products LimitedInventors: Reinhard Gluck, Peter Klein, Peter Herrmann, Ernst Rudolf Walti